Skip to content

Treatment of chronic wounds using FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting: A randomized controlled trial

Treatment of chronic wounds using FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting: A randomized controlled trial - FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting for chronic wounds

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032618
Enrollment
102
Registered
2018-05-17
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of chronic wounds is a big clinically challenging based on low graft take rates associated with current surgery, and the cell utilization and therapeutic effects for chronic wounds need to be improved.

Interventions

patients received FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting (experimental group) patients received autologous skin cell suspension and Split-

Sponsors

The First Affiliated Hospital of Sun Yat-sen University Department of Burn Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a chronic wound (defined as a wound that remained unhealed for more than 4 weeks) which required surgical debridement and skin grafting were eligible.

Exclusion criteria

Exclusion criteria: 1.Pregnant women and people aged less than 18 years old; 2.Pre-existing medical conditions that could potentially interfere with wound healing; 3.Patients diagnosed with other medical conditions that could hinder wound healing. 4.Patients considered to be at an aesthetic risk and refusal to give consent.

Design outcomes

Primary

MeasureTime frame
The rate of complete wound healing at 28 days (full re-epithelialization, without any requirement for dressing)

Secondary

MeasureTime frame
The time to achieve complete wound closure and treatment-related complications, included pain and itching

Countries

Asia(except Japan)

Contacts

Public ContactPeng Wang

The First Affiliated Hospital of Sun Yat-sen University Department of Burn Surgery

wangp46@mail2.sysu.edu.cn86-20-87755766-8235

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026